Literature DB >> 3715862

Dosage-dependent disposition of cadmium administered orally to rats.

L D Lehman, C D Klaassen.   

Abstract

This study was designed to determine whether the disposition of Cd is dependent on dose. Rats received a single dosage of Cd either orally (1, 10, 100, 1000, or 10,000 micrograms/kg) or intravenously (0.01, 0.1, 10, 100, or 1000 micrograms/kg) and were killed 7 days later to determine concentration of Cd in various organs. When administered intravenously, the concentration of Cd in tissues increased proportionally with dosage and the percentage of dose in each organ remained constant. However, when Cd was administered orally, the concentration of Cd in tissues increased more than the increase in dosage. Moreover, the percentage of the po dosage retained 7 days after administration increased from 0.40% at the 1 microgram/kg dosage to 1.65% at the 100 micrograms/kg and higher dosages. In addition, when administered orally, low dosages of Cd (1 and 10 micrograms/kg) distributed preferentially to the kidney suggesting that Cd may be absorbed as a Cd-metallothionein complex at low dosages. To determine the gastrointestinal absorption of Cd, rats were given an oral dosage of Cd (1 or 10,000 micrograms/kg) and 3 hr later organs were removed to determine Cd content. Concentrations of Cd in tissues increased more than the increase in dosage and the percent of dosage absorbed was dosage-dependent (0.35 and 1% at the 1 and 10,000 micrograms/kg dosages, respectively). At the 1 microgram Cd/kg dosage, approximately 60% of Cd in intestinal cytosol was bound to metallothionein (MT) whereas at the 10,000 micrograms Cd/kg dosage, approximately 50% of the Cd was bound to MT. These results indicate that retention of Cd following oral administration is dosage-dependent and results from increased absorption of Cd at higher dosages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715862     DOI: 10.1016/0041-008x(86)90423-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

1.  Effects of Cd2+ on transient outward and delayed rectifier potassium currents in acutely isolated rat hippocampal CA1 neurons.

Authors:  Shu Wang; Tai-Ran Xing; Ming-Liang Tang; Wu Yong; Chen-Chen Li; Liang Chen; Hui-Li Wang; Jiu-Lai Tang; Di-Yun Ruan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-02       Impact factor: 3.000

2.  Cadmium accumulation, metallothionein and glutathione levels, and histopathological changes in the kidneys and liver of magpie (Pica pica) from a zinc smelter area.

Authors:  Tadeusz Włostowski; Krzysztof Dmowski; Elzbieta Bonda-Ostaszewska
Journal:  Ecotoxicology       Date:  2010-03-27       Impact factor: 2.823

3.  Effect of phytic acid and calcium on the intestinal absorption of cadmium in vitro.

Authors:  T Turecki; R C Ewan; H M Stahr
Journal:  Bull Environ Contam Toxicol       Date:  1994-09       Impact factor: 2.151

4.  Fulvic and humic acids decrease the absorption of cadmium in the rat intestine.

Authors:  A W Glynn
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  Absorption of cadmium after a long-term oral administration of cadmium to dogs.

Authors:  K Matsuno; Y Kodama; T Kawamoto; F Kayama; K Tsuchiya
Journal:  Biol Trace Elem Res       Date:  1991-02       Impact factor: 3.738

6.  Rat primary hepatocyte cultures are a good model for examining metallothionein-induced tolerance to cadmium toxicity.

Authors:  J Liu; W C Kershaw; C D Klaassen
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

Review 7.  Metallothionein protection of cadmium toxicity.

Authors:  Curtis D Klaassen; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-09       Impact factor: 4.219

8.  Differential susceptibility to cadmium-induced liver and kidney injury in wild and laboratory-bred bank voles Myodes glareolus.

Authors:  Aneta Salińska; Tadeusz Włostowski; Ewa Oleńska
Journal:  Arch Environ Contam Toxicol       Date:  2013-04-06       Impact factor: 2.804

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.